This study was designed to compare Coxiella burnetii antibody dynamics in heifers born to vaccinated or non-vaccinated dams in a single high-producing dairy herd chronically infected with the bacterium. Antibody dynamics were examined from birth to the postpartum period in replacement heifers (n = 14) born to non-vaccinated dams (n = 7) or to dams that had been vaccinated on gestation days 171-177 (n = 7) and 192-198. Samples of blood, milk, faeces, vaginal fluid, colostrum and cotyledons (the latter two only at parturition) were obtained in the dams over the period from gestation days 171-177 to postpartum days 91-97. Blood samples were used to detect antibodies against C. burnetii and remaining samples for PCR identification of the bacterium. In their calves/heifers, blood samples for antibody determinations were collected from birth to postpartum at the time points 1-7 and 22-28 days and 3, 6 and 12 months of age; 90-96 and 210-216 days of gestation; and 22-28 days postpartum. All calves were born seronegative for C. burnetii. Irrespective of the shedding status of their mothers (7 were C. burnetii shedders), seroconversion occurred after colostrum intake in all calves born to seropositive cows (n = 9) and in two of three vaccinated seronegative dams. Thereafter antibody titres gradually declined and by 6 months of age all calves were seronegative. Seronegativity persisted until their first postpartum period. These findings indicate that cows vaccinated during advanced pregnancy transfer immunity to their calves via the colostrum. Maternal C. burnetii antibodies in calves persisted for three months in calves born both to seronegative vaccinated and seropositive dams.
Acta Veterinaria Hungarica 63, 2015 2010; Agerholm, 2013; Garcia-Ispierto et al., 2014) . Some authors have linked the presence of anti-C. burnetii antibodies to placenta retention, abortion or infertility (Krauss et al., 1987; To et al., 1995 To et al., , 1998 Hässig and Lubsen, 1998) . Others have noted no negative impacts of C. burnetii seropositivity in dairy cattle (Lange et al., 1992; Nielsen et al., 2011; Paul et al., 2012; Muskens et al., 2012) , while some even argue that seropositivity improves fertility and helps maintain pregnancy in dairy cattle .
The phase I vaccine seems to be the most protective measure against C. burnetii infection. In dairy cattle, vaccination has been noted to reduce shedding of the bacterium only in seronegative non-pregnant animals (Guatteo et al., 2008) . When used in infected animals during the peri-insemination period, vaccination did not prevent C. burnetii shedding (Guatteo et al., 2008; Rousset et al., 2009) . However, when administered during the dry-off period, while the vaccine did not reduce shedding , it was able to improve the subsequent fertility of the herd Garcia-Ispierto et al., 2015) .
Several studies have shown that C. burnetii seropositivity increases with parity (McCaughey et al., 2010; Böttcher et al., 2011; Paul et al., 2012; Tutusaus et al., 2013) and antibody levels remain stable for long periods (Guatteo et al., 2007; Garcia-Ispierto et al., 2011; Nogareda et al., 2012) . However, most likely because of the difficulty in detecting infection at the farm level , the pathogenesis of the disease is poorly understood. In a recent study , all calves born to seropositive animals tested seronegative until colostrum intake. However, to the best of our knowledge no study has examined whether colostrum antibodies persist in calves or tried to determine the exact time when calves or heifers become infected or undergo seroconversion. For farms rearing their own heifers, this type of information is essential to control C. burnetii infection at the herd level. The present study was designed to explore C. burnetii antibody dynamics from birth to the first postpartum period in replacement heifers born to vaccinated and non-vaccinated dams in a chronically infected high-producing dairy herd.
Materials and methods

Cattle and herd management
The study was performed from March 2011 to June 2014 in a commercial Holstein-Friesian dairy herd (NE Spain) including 625 lactating animals. Cows were milked three times daily. Mean annual milk production was 11,343 kg and the culling rate for the study period was 29%. The mean calf mortality rate was 9% and the mean conception rate (number of artificial inseminations per positive pregnancy diagnosis) was 33%. The cows calved all year round and were fed complete rations in line with the National Research Council recommendations (2001) . All cows were bred by artificial insemination (AI).
All animals were tuberculosis and brucellosis free, as indicated by yearly tests from 1985 to 2014. Vaccination programmes for the prevention of bovine viral diarrhoea (BVD) and infectious bovine rhinotracheitis (IBR) included the use of modified live vaccines for animals 6-8 months old. Pregnant animals were given killed vaccines during the 7th month of each gestation period. Parous cows that were not pregnant on day 150 postpartum received a further killed vaccine.
In yearly tests from 2009 to 2014, C. burnetii DNA was detected by polymerase chain reaction (PCR) in the bulk tank milk (BTM) indicating an excretion rate higher than 10 3 bacteria/mL and ELISA tests indicated a seroprevalence higher than 30% (Garcia-Ispierto et al., 2010 López-Gatius et al., 2012; Nogareda et al., 2012; Tutusaus et al., 2014) . The herd was therefore considered to be persistently infected with C. burnetii.
Efforts were made to reduce variation in the general health status of the animals so that serological changes could be attributed to factors other than the clinical condition of the heifers during the study. The final data examined were derived from 14 replacement heifers (from birth to their first parturition period) and their mothers.
Experimental design
At the study outset, 14 pregnant cows were randomly assigned to a control (non-vaccinated) (n = 7) or vaccine (n = 7) group. Cows in the vaccine group received two subcutaneous injections three weeks apart of inactivated phase I vaccine (Coxevac ® , CEVA Santé Animale, Libourne, France) on days 171-177 and days 192-198 of gestation. Each 4-mL vaccine dose contained purified corpuscular phase I C. burnetii antigens (100 µg/mL) inactivated with formaldehyde. On gestation days 171-177, at parturition and on postpartum days 1-7, 8-14, 15-21, 22-28, 29-35 and 91-97 , blood, milk, faeces, vaginal fluid, and colostrum and cotyledons (only at parturition) were collected from the cows. Blood samples in their calves were collected at birth before colostrum intake and at the ages 1-7 and 22-28 days and 3, 6 and 12 months. After pregnancy diagnosis in each heifer, blood samples were also collected at 90-96 and 210-216 days of gestation and at 22-28 days post partum.
Sampling procedures
Blood samples were collected from the coccygeal vein in dams and the jugular vein in calves (from birth to 3 months old) into heparinised vacuum tubes (BD Vacutainer™, Becton-Dickinson and Company, Plymouth, UK). Tubes were centrifuged (10 min, 1600 × g) within 30 min after collection and the plasma was stored at −20 °C until analysis.
Milk and colostrum samples were collected in a plastic sterile container for PCR. To minimise the risk of contamination during the collection process, teats were washed in clean water and then each teat end was scrubbed with antiseptic teat wipes. Finally, milk and colostrum were collected from the four teats after elimination of the first stream. Samples were frozen at -20 °C prior to analysis.
After disinfection of the vulva with iodine solution, a vaginal swab was obtained and stored at -20 °C. Faecal samples were collected into sterile containers using a rectal examination glove.
Placenta specimens were obtained immediately after parturition. After washing the perineum with iodine solution, three cotyledons were excised using rectal palpation gloves. All specimens were stored after their collection at -20 °C until PCR analysis.
Laboratory tests
Coxiella burnetii antibodies. A commercial indirect ELISA, CoxLS kit (LSIVET RUMINANT Milk/Serum Q FEVER; Laboratoire Service International, Lissieu, France) was used to determine antibodies to C. burnetii according to the manufacturer's instructions. After validation studies (data not shown) we used plasma samples instead of blood serum. A cocktail of both antigen phases (I and II) was used in this assay to detect total anti-C. burnetii immunoglobulins G (IgG) (Guatteo et al., 2008) . The results were expressed as S/P ratios. A sample was scored positive when the S/P ratio > 0.4. The sensitivity and specificity of this ELISA test have been estimated to be 85% and 95%, respectively (Courcoul et al., 2010) .
Polymerase chain reaction. Coxiella burnetii was PCR-detected in the cotyledons and colostrum, milk, faeces and vaginal fluid samples using a commercial kit targeting the repeat transposon-like region of C. burnetii (LSI Taqvet Coxiella burnetii ® ; Laboratoire Service International) according to the manufacturer's instructions. The positive control used was a solution containing 10 5 C. burnetii/mL (provided by UR INRA IASP, Nouzilly, France). The negative control sample used was DNase Rnase-free water. DNA was extracted from the different samples using the QIAmp DNA minikit ® (Qiagen S.A., Courtaboeuf Cedex, France) according to the manufacturer's instructions. For the milk or vaginal mucus samples, DNA was extracted directly from 200 µL of raw milk or 200 µL of the obtained mucous dilution. For the faeces samples, 1 g of the original sample was weighed and mixed by vortexing for 30 s with 4 mL of DNase RNase-free water and 400 µL then collected. Finally, samples were centrifuged at 6000 × g for 1 min and 200 µL of the supernatants used for DNA extraction. For the cotyledon samples, DNA was extracted from 25 mg of tissue cut into small pieces and placed in a 1.5-mL microcentrifuge tube.
Acta Veterinaria Hungarica 63, 2015
Data collection and analysis
Dams. The following data were recorded for each cow: parity (primiparous versus multiparous cows), treatment group (control vs. vaccination), and C. burnetii seropositivity and shedding status on gestation days 171-177, at parturition and on postpartum days 1-7, 8-14, 15-21, 22-28, 29-35 and 91-97. When one or more PCR-positive samples (milk, faeces, vaginal fluid, colostrum or placenta) were recorded on one or more sampling days, the cow was recorded as shedding-positive.
Replacement heifers. Coxiella burnetii serostatus in each calf/heifer was determined at birth before colostrum intake and at the ages of 1-7 and 22-28 days, at 3, 6 and 12 months, at 90-96 and 210-216 days of gestation and at 22-28 days post partum.
For each calf/heifer, C. burnetii serostatus at day 1-7 of age was compared with the serostatus (C. burnetii seronegative vs. seropositive) of its dam according to the mother's shedding status, parity and treatment group using a χ 2 test. The effects of these variables on the S/P ratio recorded in calves/heifers were assessed by GLM repeated measures analysis of variance. All statistical tests were performed using the SPSS package version 18.0 (SPSS Inc., Chicago, IL, USA). Significance was set at P < 0.05.
Results
Dams
The mean (± SD) lactation number was 1.93 ± 0.73 and ranged from 1 to 4. At the study outset, there were 5 (71.4%) and 4 (57.1%) C. burnetii-seropositive animals in the control and vaccination groups, respectively. Bacterial shedding (at least at one time point) was detected in 7 (50%) dams, of which 5 (71.4%) were C. burnetii seropositive. Seroconversion was not observed in any of the seronegative dams in the control group, whilst seroconversion was recorded in two of the three (66.7%) seronegative dams in the vaccination group. Seropositive cows maintained their seropositivity throughout the study period.
Replacement heifers
Data regarding the serostatus of each calf according to the characteristics of its mother (serostatus, shedding status, parity, treatment group) are provided in Table 1 . Upon birth, all the calves were seronegative for C. burnetii. In 11 of the 14 calves (78.6%), seroconversion was observed after colostrum intake, 9 of which had been born to seropositive dams (non-vaccinated and vaccinated) and two to seronegative vaccinated dams. The remaining three seronegative calves were born to one seronegative vaccinated dam and to two seronegative control dams, respectively. Two (18.2%) and three (27.3%) of the 11 initially seroposi-Acta Veterinaria Hungarica 63, 2015 tive calves became seronegative at 22-28 days and 3 months of age, respectively. The remaining six seropositive calves became seronegative at 6 months of age. Seronegativity remained stable from six months to the end of the study period (Fig. 1) . The χ 2 test revealed a higher C. burnetii seropositivity rate on day 1-7 of age in calves born to seropositive dams than seronegative dams (81.8% vs. 18.2%, respectively, P = 0.027). No other significant differences were detected. Table 1 Coxiella burnetii serostatus of replacement calves after colostrum intake (at 1-7 days of age) according to the characteristics of their mothers The mean age at pregnancy in the heifers was 15.1 ± 0.9 months, ranging from 14 to 17 months. No associations were identified throughout the study period between heifer seropositivity and C. burnetii shedding status, parity or vaccination in the corresponding dams by GLM repeated measures ANOVA. Calves born to seropositive dams showed significantly higher anti-C. burnetii antibody levels from 1-7 days to 3 months of age compared with those born to seronegative dams (between subject effects, P = 0.026) (Fig. 2) . 
Discussion
To the best of our knowledge, this is the first study to address C. burnetii antibody dynamics from birth to parturition in replacement heifers. Seroconversion was detected after colostrum intake in all calves born to seropositive dams and in calves born to two of three vaccinated seronegative dams. By 6 months of age, all calves were seronegative and remained so until their first postpartum period.
Coxiella burnetii antibodies initially transferred to calves via the mothers' colostrum gradually declined over time. Hence, by 6 months of age all the animals were seronegative. Similar maternal antibody dynamics have been reported for Schmallenberg virus (Elbers et al., 2014) as well as IBR and BVD (Menanteau-Horta et al., 1985) . This type of information is essential for the design of an effective vaccination schedule since colostral antibodies may interfere with vaccination (Menanteau-Horta et al., 1985; Vitour et al., 2011; Downey et al., 2013) . The phase I C. burnetii vaccine is usually given to nulliparous heifers of 12 months or older (Taurel et al., 2014) . The present findings suggest that vaccination in heifers could be brought forward to six months of age. In agreement with the results of our previous work , all newborn calves were seronegative before colostrum intake, suggesting a lack of vertical transmission. In two of three vaccinated cows, antibodies were transferred via the colostrum to their calves. This indicates passive immunisation of calves born to vaccinated dams as described in other infectious diseases affecting cattle such as bovine rotavirus, bovine coronavirus, bovine parvovirus, Escherichia coli and Cryptosporidium parvum (Kohara et al., 1997; Perryman et al., 1999; Burton et al., 2011) . Thus, vaccinating cows during the dry-off period seems to be a good strategy to control Q fever on dairy farms raising their own replacement animals. However, according to the present data, in one of three seronegative vaccinated dams, antibodies were not transferred to the newborn calf via the colostrum. There are several descriptions in the literature of multiparous shedding seronegative cows that do not raise a humoral response against C. burnetii (Guatteo et al., 2007; Rousset et al., 2009; Garcia-Ispierto et al., 2011; Hansen et al., 2011; Nogareda et al., 2012) . This lack of response is likely attributable to genetic resistance to infection or the immunotolerance of these animals.
No links were detected between calf C. burnetii seropositivity and dam factors such as parity, Coxiella-shedding status and vaccination status. In contrast, several studies have identified parity (McCaughey et al., 2010; Böttcher et al., 2011; Paul et al., 2012; Tutusaus et al., 2013) , C. burnetii shedding (Guatteo et al., 2007; Courcoul et al., 2010) and vaccination against the bacterium as maternal factors related to the C. burnetii seropositivity of their offspring. The lack of effects of these factors observed here may be explained by our small sample size.
In conclusion, the results of this study indicate that cows vaccinated at an advanced stage of pregnancy transferred immunity towards C. burnetii to their calves via the colostrum. Maternal C. burnetii antibodies persisted for three months in calves born to both seronegative vaccinated and seropositive dams.
